Scientific publications

Immunogenic cell death and cross-priming are reaching the clinical immunotherapy arena

Melero I. [SP], Arina A., Murillo O., Dubrot J., Alfaro C., Pérez-Gracia J.L [SP]., Bendandi M., Hervás-Stubbs S.
Centro de Investigación Médica Aplicada, Clínica Universitaria and School of Medicine, University of Navarra, Pamplona, Spain

Magazine: Clinical Cancer Research

Date: Apr 1, 2006

Immunology [SP] Cell Therapy Area [SP]

In this issue of Clinical Cancer Research, Saji et al. show the preclinical therapeutic efficacy of combining photodynamic therapy and intratumoral injection of dendritic cells (DC) in s.c. transplanted tumors.

The investigators have used systemic doses of a hydrophilic photosensitizer and a laser beam directed at s.c. malignant lesions implanted in mice. Once this procedure had been done, bone marrow–derived DC were injected inside the experimental tumor lesions. Tumors derived from two different cell lines have been treated with this regime, and compelling data has shown synergistic effects of the therapeutic combination for both locally treated tumor and distantly implanted lesions. Additional experiments showed that the therapeutic effects correlate with a cellular immune response against tumor antigens that includes detection of cytolytic T lymphocytes that, if adoptively transferred, protect na?¨ve recipient mice from tumor challenge.

The cellular and molecular mechanisms involved in the induction of these highly efficacious therapeutic effects have not been addressed, but are likely related to the biological phenomena of tumor antigen cross-priming and immunogenic cell death. These mechanisms are now an important focus of research in immunology, among other reasons because of their promising implications to attain synergistic combinations of radiotherapy and/or chemotherapy with immunotherapy.

The most exciting points raised by this article from the group of Edgar Engleman are the potency of the treatment on the poorly immunogenic B16 melanoma model and the feasibility of the approach for clinical translation.

CITATION  Clin Cancer Res. 2006 Apr 15;12(8):2385-9

you maybe interested


The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra


The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.

Imagen profesionales de la Clínica Universidad de Navarra


Learn why we are different from other healthcare centers. Quality, speed, comfort and results.

Imagen del edificio de la Clínica Universidad de Navarra